The Himalaya Drug Company (HDC) on Thursday launched in Bangalore two new drugs, Menosan (for treating menopausal symptoms) and Reosto (for countering osteoporosis), under its medicinal
range of products. These two drugs are expected to bring in Rs 6-7 crore to HDC covers before this financial year comes to a close.

Phillpe J. Haydon, general manager (Pharma Marketing), HDC, said clinical trials have shown that Menosan is considered to be an ideal alternative to Hormone Replacement Therapy (HRT) without the associated risks.

Menosan, company officials said, would improve hormone utilisation and overall hormone balance. It would provide relief from excessive sweating, insomnia and headache, the symptoms associated with menopause. Reosto, being a natural source of calcium, is expected to eliminate the risk of abnormally high calcium and vitamin D levels in blood.